Impact Biomedical (IBO) Share-based Compensation (2024 - 2026)
Impact Biomedical's (IBO) quarterly Share-based Compensation came in at $1.4 million in Q1 2026, up 71900.0% YoY from N/an in Q1 2025, and up 17900.0% on a QoQ basis from $8000.0 in Q4 2025.
Impact Biomedical (IBO) Share-based Compensation (2024 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 3 years of Share-based Compensation data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 71900.0% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 6809.52% YoY) and the FY2025 annual result came in at $13000.0, down 31.58% from the prior year.
- Share-based Compensation climbed to $1.4 million in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.4 million in Q1 2026 to a low of $1000.0 in Q3 2025.
- A 3-year average of $245333.3 and a median of $5000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2025 — Share-based Compensation tumbled 57.89% — and 2026, when it jumped 71900.0%.
- Tracing IBO's Share-based Compensation over 3 years: stood at $19000.0 in 2024, then plunged by 57.89% to $8000.0 in 2025, then surged by 17900.0% to $1.4 million in 2026.
- The last three Share-based Compensation figures came in at $1.4 million (Q1 2026), $8000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Impact Biomedical | 47.30 Mn | 47.29 Mn | 2,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2024 | 19,000.00 |